씨젠
36,900KRWMarket close of 10/20 (Tue)
Down -2.89%-1,100KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)36,250KRWDown -1.76%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 37,750
- High
- 38,550
- Low
- 36,400
- Day range
- Day range low 36,400 high 38,550, open 37,750, close 36,900, previous close 38,000
- Volume
- 25×10K shares
- 9.3B KRW 0.84× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
88%1-year close range 21,850 to 38,900 won, 88% up from the low
88% of the way up from the lowest close in 1 year (252 sessions) · -5.1% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range-2.89%-2.89%, 1.5× the usual (20-session average ±1.94%)That day -2.89% · usual ±1.94% · large-move threshold ±3.9%
- Trading valueusual range0.8×9.3B KRW, 0.8× the 20-session average0.84× the 20-session average · check threshold 3×
- Earningsusual range61.7B KRWOperating income over the last four quarters 61.7B KRW
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+6.6B KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 26 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.